Literature DB >> 9217620

Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts.

B L Røder1, D A Wandall, F Espersen, N Frimodt-Møller, P Skinhøj, V T Rosdahl.   

Abstract

PURPOSE: To investigate the neurologic manifestations of infective endocarditis caused by Staphylococcus aureus in a population of nondrug addicts with special emphasis on the clinical presentation, epidemiology, and mortality. PATIENTS AND METHODS: During the period from 1982 to 1991 a total of 8,514 cases of bacteremia with S aureus were reported to the Staphylococcus Laboratory, Copenhagen, Denmark. The medical records of cases of suspected infective endocarditis were retrospectively reviewed and classified according to the new diagnostic criteria for endocarditis proposed by Durack.
RESULTS: A total of 260 cases from 63 hospitals fulfilled the diagnostic criteria. Overall, 91 patients (35%) experienced neurologic manifestations. Sixty-one presented with neurologic symptoms, whereas 30 patients developed neurologic complications at various intervals (median: 10 days) after the debut of the disease. The most frequent neurologic manifestation was unilateral hemiparesis, which occurred in 41 patients (45%). Forty-two percent of the females had neurologic manifestations compared to only 30% of the males (P = 0.06). Cases with native mitral valve infection had a significantly higher frequency of neurologic manifestations compared with all other valvular involvement (44% versus 29%, P = 0.02) but the frequency of neurologic complications was only nonsignificantly higher in those patients with native mitral valve infection than in those patients with native aortic valve infection (44% versus 31%, P = 0.10). Only two of the patients with tricuspid valve infection and none of those with congenital heart disorder experienced neurologic manifestations. A neurologic manifestation occurred in 22 (35%) of the 63 episodes in which vegetations were detected on the echocardiograms, compared with 17 (26%) of the 65 episodes without vegetations (P = 0.38). The mortality was 74% in patients with major neurologic manifestations and 56% in patients without neurologic manifestations (P = 0.008). In patients with neurologic complications the mortality was significantly higher among those treated with antibiotics alone as compared with those treated surgically (65 of 81, 80% versus 2 of 10, 20%; P = 0.0003).
CONCLUSIONS: In a population of nondrug addicts with infective endocarditis caused by S aureus the following main conclusions can be drawn: neurologic manifestations occur with a higher frequency in patients with native mitral valve infection. The presence of vegetations on echocardiograms is not a risk factor for developing neurologic complications but this conclusion is based on the results of transthoracic echocardiograms performed in only one half of the patients. The majority of the neurologic manifestations occur on presentation or shortly thereafter and the risk of recurrent embolism is low. Mortality is increased in patients with neurologic manifestations. A neurologic event per se may constitute an indication for surgical treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9217620     DOI: 10.1016/s0002-9343(97)00090-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  27 in total

1.  Echocardiography for the Diagnosis of Staphylococcus aureus Infective Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

2.  Brain magnetic resonance findings in infective endocarditis with neurological complications.

Authors:  Asako Azuma; Keiko Toyoda; Toshihiro O'uchi
Journal:  Jpn J Radiol       Date:  2009-05-03       Impact factor: 2.374

3.  Comparison of clinical and morphological characteristics of Staphylococcus aureus endocarditis with endocarditis caused by other pathogens.

Authors:  G Nadji; J P Rémadi; F Coviaux; A Ali Mirode; A Brahim; M Enriquez-Sarano; C Tribouilloy
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

4.  My paper 10 years later: infective endocarditis in the intensive care unit.

Authors:  Michel Wolff; Bruno Mourvillier; Romain Sonneville; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-09-20       Impact factor: 17.440

Review 5.  Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.

Authors:  Rasmus V Rasmussen; Vance G Fowler; Robert Skov; Niels E Bruun
Journal:  Future Microbiol       Date:  2011-01       Impact factor: 3.165

6.  Infective Endocarditis in Adults with Congenital Heart Disease.

Authors:  Ulf Thilén
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

7.  Pre-operative stroke and neurological disability do not independently affect short- and long-term mortality in infective endocarditis patients.

Authors:  Mahmoud Diab; Albrecht Guenther; Christoph Sponholz; Thomas Lehmann; Gloria Faerber; Anna Matz; Marcus Franz; Otto W Witte; Mathias W Pletz; Torsten Doenst
Journal:  Clin Res Cardiol       Date:  2016-04-27       Impact factor: 5.460

8.  Issues in the Management of Endocarditis Caused by Resistant Gram-positive Organisms.

Authors:  Martin E. Stryjewski; Vivian H. Chu; Christopher H. Cabell; Vance G. Fowler
Journal:  Curr Infect Dis Rep       Date:  2004-08       Impact factor: 3.725

9.  Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients.

Authors:  Bruno Mourvillier; Jean-Louis Trouillet; Jean-François Timsit; Jérome Baudot; Jean Chastre; Bernard Régnier; Claude Gibert; Michel Wolff
Journal:  Intensive Care Med       Date:  2004-09-15       Impact factor: 17.440

10.  beta-Neurexin is a ligand for the Staphylococcus aureus MSCRAMM SdrC.

Authors:  E Magda Barbu; Vannakambadi K Ganesh; Shivasankarappa Gurusiddappa; R Chris Mackenzie; Timothy J Foster; Thomas C Sudhof; Magnus Höök
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.